BUFFALO, N.Y. — University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into ...

A study that investigates low-dose ketamine (LDK) as an adjunct to morphine for treating acute pain has been published in the ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

In recent years, ketamine — long known for its misuse as a psychedelic party drug — has become a “life-saving” medicine for ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

Des Plaines, IL - A new study that investigates low-dose ketamine (LDK) as an adjunct to morphine for treating acute pain has ...

In addition to the SP-26 agreement, Kymanox is Silo’s regulatory partner for SPC-15, a targeted prophylactic treatment for stress-induced affective disorders including PTSD.

Ketamine therapy can change lives for those struggling with treatment-resistant depression, anxiety, or chronic pain.

WHILE KETAMINE OFTEN comes up in conversations about psychedelic medicine, technically it’s part of a class of drugs called ...